Roman Yelensky

Company: Gritstone Oncology

Job title: Chief Technology Officer

Seminars:

Neoantigen Targeted Cancer Immunotherapy in the Clinic 8:00 am

• Neoantigens are key tumor specific targets that may be targeted therapeutically • Neoantigens can be identified for each patient using NGS and machine learning • Immunoassays and ctDNA can be used to evaluate neoantigen immunotherapies in the clinicRead more

day: Day One